Wellington Management Group LLP Has $157.14 Million Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Wellington Management Group LLP lowered its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 0.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,575,456 shares of the medical instruments supplier’s stock after selling 12,551 shares during the quarter. Wellington Management Group LLP owned about 6.53% of ICU Medical worth $157,136,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. FMR LLC grew its holdings in ICU Medical by 89.9% during the 3rd quarter. FMR LLC now owns 1,124,995 shares of the medical instruments supplier’s stock worth $133,886,000 after acquiring an additional 532,483 shares during the last quarter. Schroder Investment Management Group raised its position in ICU Medical by 35.8% in the 4th quarter. Schroder Investment Management Group now owns 433,852 shares of the medical instruments supplier’s stock worth $43,272,000 after purchasing an additional 114,344 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in ICU Medical by 28.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 324,867 shares of the medical instruments supplier’s stock worth $38,662,000 after buying an additional 71,258 shares in the last quarter. WCM Investment Management LLC boosted its position in ICU Medical by 37.5% in the 4th quarter. WCM Investment Management LLC now owns 242,808 shares of the medical instruments supplier’s stock valued at $24,223,000 after buying an additional 66,221 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in ICU Medical by 4.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 220,624 shares of the medical instruments supplier’s stock valued at $22,005,000 after buying an additional 9,196 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Insider Buying and Selling at ICU Medical

In other news, insider Ben Sousa sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $105.55, for a total transaction of $211,100.00. Following the sale, the insider now owns 1,319 shares of the company’s stock, valued at $139,220.45. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, insider Ben Sousa sold 2,000 shares of the company’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $105.55, for a total value of $211,100.00. Following the completion of the transaction, the insider now directly owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, COO Christian B. Voigtlander sold 12,539 shares of the firm’s stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $103.95, for a total transaction of $1,303,429.05. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,839 shares of company stock valued at $1,546,014. Company insiders own 6.70% of the company’s stock.

ICU Medical Stock Performance

Shares of ICUI stock opened at $119.61 on Thursday. The stock has a market cap of $2.91 billion, a PE ratio of -48.82 and a beta of 0.73. The stock has a 50-day moving average of $104.09 and a 200-day moving average of $100.67. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09. ICU Medical, Inc. has a one year low of $78.28 and a one year high of $187.95.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the consensus estimate of $0.54 by $0.06. The firm had revenue of $566.66 million during the quarter, compared to the consensus estimate of $553.15 million. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. As a group, sell-side analysts expect that ICU Medical, Inc. will post 3.5 earnings per share for the current year.

Analyst Ratings Changes

ICUI has been the topic of a number of research reports. Raymond James upgraded shares of ICU Medical from a “market perform” rating to an “outperform” rating and set a $135.00 target price on the stock in a research report on Monday. KeyCorp raised their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, ICU Medical currently has an average rating of “Moderate Buy” and a consensus price target of $127.00.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.